-
Product Insights
NewFatty Acid Synthase – Drugs In Development, 2024
The Fatty Acid Synthase pipeline drugs market research report outlays comprehensive information on the Fatty Acid Synthase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Infectious Disease, Oncology, and Metabolic Disorders which include indications of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Tuberculosis, Respiratory Syncytial Virus (RSV) Infections, Breast Cancer, Colon Cancer, and...
-
Product Insights
NewStearoyl CoA Desaturase – Drugs In Development, 2024
The Stearoyl CoA Desaturase pipeline drugs market research report outlays comprehensive information on the Stearoyl CoA Desaturase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Oncology, Central Nervous System, and Metabolic Disorders which include indications of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Colorectal Cancer, Colon Cancer, Lewy Body Dementia, Parkinson's Disease, Obesity,...
-
Product Insights
NewSignal Transducer And Activator Of Transcription 6 – Drugs In Development, 2024
The Signal Transducer And Activator Of Transcription 6 pipeline drugs market research report outlays comprehensive information on the Signal Transducer And Activator Of Transcription 6 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Immunology, and Dermatology which include indications of Colorectal Cancer, Colon Cancer, Asthma, Idiopathic Pulmonary Fibrosis, Unspecified Immunological Disorders, Inflammation, and Atopic Dermatitis...
-
Product Insights
NewCholecystokinin Receptor Type A – Drugs In Development, 2024
The Cholecystokinin Receptor Type A pipeline drugs market research report outlays comprehensive information on the Cholecystokinin Receptor Type A targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Oncology, Metabolic Disorders, and Gastrointestinal which include indications of Pain, Anxiety Disorders, Lung Cancer, Colon Cancer, Obesity, Diabetes, and Pancreatitis. It also reviews key players involved in...
-
Product Insights
NewComputed Tomography (CT) Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Computed Tomography (CT) is a powerful, non-destructive evaluation technique used for producing 2D and 3D cross-sectional image of an object from a flat X-ray image. Computed Tomography (CT) is used on patients with a high risk of colon cancer, or full-motion heart scans for patients with high risk of heart disease. It can also be used for image complex fractures, detect infarction, tumors, calcifications, hemorrhage and bone trauma and also acute and chronic changes in the lung parenchyma etc. The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACP-017 in Vaginal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACP-017 in Vaginal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACP-017 in Vaginal Cancer Drug Details: Small molecule is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACP-017 in Penile Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACP-017 in Penile Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACP-017 in Penile Cancer Drug Details: Small molecule is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACP-017 in Vulvar Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACP-017 in Vulvar Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACP-017 in Vulvar Cancer Drug Details: Small molecule is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACP-017 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACP-017 in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACP-017 in Esophageal Cancer Drug Details: Small molecule is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACP-017 in Merkel Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACP-017 in Merkel Cell Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACP-017 in Merkel Cell Carcinoma Drug Details: Small molecule is...